Napredna pretraga

Pregled bibliografske jedinice broj: 510064

Tau protein isoforms and phosphorylation in developement and Alzheimers disease


Mladinov, Mihovil; Boban, Marko; Boban, Marina; Grbić, Kristina; Mimica, Ninoslav; Šimić, Goran
Tau protein isoforms and phosphorylation in developement and Alzheimers disease // Abstracts of the 22nd Conference of Alzheimer's Disease International - "Dementia - A challenge for the 21st century - 100 Years of Alzheimer's Disease"
Berlin: Alzheimer's Disease International and Deutsche Alzheimer Gessellschaft e. V., 2006. str. 104-104 (poster, međunarodna recenzija, sažetak, stručni)


Naslov
Tau protein isoforms and phosphorylation in developement and Alzheimers disease

Autori
Mladinov, Mihovil ; Boban, Marko ; Boban, Marina ; Grbić, Kristina ; Mimica, Ninoslav ; Šimić, Goran

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Abstracts of the 22nd Conference of Alzheimer's Disease International - "Dementia - A challenge for the 21st century - 100 Years of Alzheimer's Disease" / - Berlin : Alzheimer's Disease International and Deutsche Alzheimer Gessellschaft e. V., 2006, 104-104

Skup
22nd Conference of Alzheimer's Disease International - "Dementia - A challenge for the 21st century - 100 Years of Alzheimer's Disease"

Mjesto i datum
Berlin, Njemačka, 12-14.10.2006.

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Tau proteins; Alzheimers disease; phosphorylated tau

Sažetak
Tau proteins belong to the microtubule-associated proteins (MAP) group and are involved in microtubule assembly, stabilization and cytoskeleton maintenance. The biological activity of tau is controlled mostly by phosphorylation and is developmental^ regulated. It is high in the fetal period and decreases with age. A single gene on chromosome 17 encodes the human tau protein. In the adult human brain, six tau isoforms are expressed. The unique expression pattern of human tau isoforms could represent a link to the particular vulnerability of humans to neurodegenerative disorders, particularly Alzheimer's disease (AD). AD is characterized by intraneuronal and glial fibrillar lesions formed by tau proteins, which are abnormally phosphorylated. Phosphorylation of tau proteins is probably the most important cause of their aggregation. Phosphorylated tau is the most accurate biomarker in the cerebrospinal fluid (CSF) for the diagnosis of AD. The main goals of the project in our laboratory are: 1. to determine how abnormalities of selected phospho-tau epitopes 181, 199, 202/205, 231, 396/404 and 422, ratio of 3R/4R tau isoforms and the total tau in CSF, as revealed by enzyme-linked immunosorbent assay (ELISA), Western blot and mass spectrometry, relate to alterations in glutamatergic transmission, MRI-determined entorhinal and hippocampal atrophy and cognitive changes ; 2. to identify and evaluate the possible role of reactivated fetal kinases in tau phosphorylation in AD, and to test the presumed protective action of fetal tau isoform on tau polymerization in neuronal cell culture. We expect to obtain new knowledge relevant for tracking the progression of neurofibrillary degeneration and early detection of AD.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

Napomena
Sažetak je osim na engleskom naveden i na njemačkom jeziku